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yosin VI plays a role in the maintenance of
Golgi morphology and in exocytosis. In a
yeast 2-hybrid screen we identified optineurin
as a binding partner for myosin VI at the Golgi complex
and confirmed this interaction in a range of protein inter-
action studies. Both proteins colocalize at the Golgi
complex and in vesicles at the plasma membrane. When
optineurin is depleted from cells using RNA interference,
myosin VI is lost from the Golgi complex, the Golgi is
fragmented and exocytosis of vesicular stomatitis virus
M
 
G-protein to the plasma membrane is dramatically reduced.
Two further binding partners for optineurin have been
identified: huntingtin and Rab8. We show that myosin VI
and Rab8 colocalize around the Golgi complex and in
vesicles at the plasma membrane and overexpression of
constitutively active Rab8-Q67L recruits myosin VI onto
Rab8-positive structures. These results show that optineurin
links myosin VI to the Golgi complex and plays a central
role in Golgi ribbon formation and exocytosis.
 
Introduction
 
In membrane trafficking pathways, motor proteins moving
along cytoskeletal tracks play a major role in transporting
vesicles between donor and acceptor compartments and may
also be involved in processes such as cargo sorting, vesicle
formation, and steady-state localization of organelles. Short-
range movement of cargo or vesicles along actin filaments,
around internal organelles, or within the cortical regions of the
cell is powered by members of the myosin superfamily, which
is comprised of at least 18 different classes (Hodge and Cope,
2000; Berg et al., 2001). Although in recent years the localization
and functions of a few of these myosins have been identified,
there is still limited information regarding the molecular mech-
anism linking myosin function and cargo attachment. For
example, how does a myosin recognize its cargo; how is the
interaction regulated and what influence does cargo binding
have on motor activity?
Myosin VI is a multifunctional motor protein found in a
number of different intracellular compartments including en-
docytic vesicles (Buss et al., 2001b; Aschenbrenner et al., 2003),
membrane ruffles (Buss et al., 1998), the Golgi complex, and
secretory vesicles (Buss et al., 1998; Warner et al., 2003).
Unlike all the other myosins that have been studied so far that
move toward the plus end of actin filaments, myosin VI moves
toward the minus end of actin (Wells et al., 1999). Functional
studies have indicated that myosin VI plays a major role in
endocytic and secretory membrane traffic pathways (Buss et
al., 2001b; Warner et al., 2003) and it has been postulated that
the diverse functions of myosin VI are mediated by interaction
with a number of different binding partners (Buss et al., 2004).
Recently, three binding partners of myosin VI were identified,
Dab2, GIPC, and SAP97, all of which target myosin VI to
vesicular compartments (Bunn et al., 1999; Morris et al., 2002;
Wu et al., 2002). So far, the best-characterized myosin VI–
binding partner is Dab2; its interaction with myosin VI has
been shown to form a dynamic link between cell surface receptors,
clathrin-mediated endocytosis, and the actin cytoskeleton (Mor-
ris and Cooper, 2001; Morris et al., 2002). In contrast, no bind-
ing partners have been identified that targets myosin VI to the
Golgi complex and the secretory pathway.
In this paper, we have identified and characterized opti-
neurin, a novel myosin VI–binding partner, which is found at
the Golgi complex. Optineurin was first discovered as a binding
partner of the adenoviral protein E3-14.7K (14.7K-interacting
protein-2 and therefore named FIP-2) and was shown to protect
infected cells from TNF-
 

 
–induced cytolysis (Li et al., 1998b).
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It is a conserved 67-kD protein with multiple leucine zipper do-
mains and a putative zinc finger domain at the COOH termi-
nus. Optineurin shows strong homology (53% identity) with
NF-
 

 
B essential modulator and was therefore also called
NEMO-related protein (Schwamborn et al., 2000). Mutations
in the human optineurin gene are associated with adult-onset
open angle glaucoma (hence it was named “optic neuropathy
inducing” protein optineurin; Rezaie et al., 2002).
Although optineurin was previously localized to the Golgi
complex (Schwamborn et al., 2000; Stroissnigg et al., 2002) its
functions at this organelle have not yet been established. How-
ever, two binding partners for optineurin have been identified
which link it to membrane trafficking events. One is huntingtin,
the protein mutated in the neurodegenerative disorder Hunting-
ton’s disease (Faber et al., 1998), and the other is the small
GTPase Rab8 (Hattula and Peranen, 2000). Although the precise
cellular functions of the wild-type huntingtin protein are not
known, its intracellular localization to the Golgi complex and to
endocytic and exocytic vesicles (DiFiglia et al., 1995; Velier et
al., 1998), as well as the identity of its binding partners (Harjes
and Wanker, 2003), suggests a role in membrane trafficking
pathways (Gauthier et al., 2004). The other optineurin binding
partner Rab8 belongs to a large family of small GTPases that
participate in and regulates intracellular membrane trafficking
pathways (Zerial and McBride, 2001). In their active GTP-
bound state different Rab proteins bind to different membrane
compartments and recruit specific effector proteins, which are
not only involved in docking and fusion with the target mem-
brane but also in the formation of transport vesicles and in bind-
ing motor proteins for vesicle transport (Zerial and McBride,
2001; Hammer and Wu, 2002; Seabra and Coudrier, 2004).
Several examples of motor protein–Rab complexes are known;
for example those involving microtubule motors such as the ki-
nesin-like protein (Rabkinesin-6) and Rab6 as well as actin-
based motor complexes such as myosin Va and Rab27a and
myosin Vb and Rab11 (Hammer and Wu, 2002).
Rab8 interacts specifically with the NH
 
2
 
 terminus of op-
tineurin (Hattula and Peranen, 2000). Rab8 has been localized
to the Golgi region, to TGN-derived transport vesicles and to
the plasma membrane (Huber et al., 1993b) and has been
shown to regulate biosynthetic trafficking pathways from the
TGN to the cell surface (Huber et al., 1993b; Ang et al., 2003).
In our present study, we have identified an RRL se-
quence in the tail domain of myosin VI that binds to a site in
the COOH-terminal region of optineurin. Both proteins colo-
calize at the Golgi complex and in vesicular structures close
to the plasma membrane. The depletion of optineurin using
small interfering RNA (siRNA) techniques drastically alters the
morphology of the Golgi complex and reduces significantly
transport of vesicular stomatitis virus G-protein (VSV-G) to
the cell surface indicating that optineurin plays an important
role in Golgi ribbon formation and in exocytosis. In addition,
depletion of optineurin causes a marked reduction in the
amount of myosin VI associated with the Golgi complex sug-
gesting that optineurin is the anchor for myosin VI at this or-
ganelle. We further show that myosin VI colocalizes with
Rab8 at the Golgi complex and at the plasma membrane,
which is interesting, because Rab8 is a regulator of post-Golgi
membrane traffic from the TGN to the plasma membrane.
 
Results
 
Optineurin binds to the COOH-terminal 
tail of myosin VI
 
The COOH-terminal tail domain of myosin VI is required for
targeting to intracellular locations such as clathrin-coated vesi-
cles (Buss et al., 2001a) and the Golgi complex (Warner et al.,
2003). To identify binding partners for myosin VI in the Golgi
complex we used the whole tail of myosin VI as a bait in a
yeast two-hybrid screen of a human umbilical vein epithelial
cell cDNA library (Morris et al., 2002). A 375–amino acid
COOH-terminal fragment of optineurin (residues 198–577)
was identified in the screen as a myosin VI–binding partner
(Fig. 1 A). To confirm this interaction both myosin VI and op-
tineurin were overexpressed in CHO cells and the binding was
measured in a mammalian two-hybrid assay (Fig. 1 B). Dele-
tion mutants of optineurin revealed that the myosin VI–binding
site on optineurin is between amino acids 412 and 520 (not de-
picted). To determine the site on myosin VI that binds to op-
tineurin a combination of deletion mutants followed by site-
directed mutagenesis was used (Fig. 1 B). The results indicate
that the globular tail (GT; aa 1034–1276) contains the binding
site, because the NH
 
2
 
-terminal helical part of the tail (HT; aa
845–1033; Fig. 1 B, columns 1 and 2) did not bind. Further-
more, myosin VI interaction with optineurin does not require
the large insert (LI) found in some isoforms (Fig. 1 B, columns
3 and 4); this part of the tail has previously been shown to be
involved in targeting myosin VI to clathrin-coated vesicles at
the apical domain of polarized cells (Buss et al., 2001b). Be-
cause deletion of the COOH-terminal 159 aa of the myosin VI
tail did not abolish binding (Fig. 1 B, column 5), we used site-
directed mutagenesis to change three adjacent residues at a
time to alanine in order to narrow down the binding site in the
remainder of the GT region, i.e., between aa 1060 and 1117.
Fig. 1 B shows that changing WKS to AAA, KVY to AAA,
and REE to AAA did not reduce binding (Fig. 1, columns 6, 7,
and 9), however mutating RRL to AAA abolished binding of
the myosin VI tail to optineurin (column 8), clearly showing
that these residues constitute the binding site for optineurin.
In vitro phosphorylation studies using recombinant p21–
activated kinase (PAK; Buss et al., 1998) and the tail of myosin
VI expressed in 
 
E. coli
 
 indicated that threonine 1088 and threo-
nine 1091 (the sequence TINT; Fig. 1 A) are potential phos-
phorylation sites (unpublished data). These threonines are also
phosphorylated in vivo, because when full-length myosin VI
was isolated from A431 cells by immunoprecipitation and sub-
jected to MALDI mass spectrometric analysis a peptide con-
taining this phosphorylated TINT motif was detected. This
peptide was dephosphorylated after alkaline phosphatase treat-
ment (unpublished data). We mutated these two threonines to
either alanines or glutamates to mimic the nonphosphorylated
and phosphorylated states respectively in order to test their ef-
fects on the binding of myosin VI to optineurin in the mamma-
lian two-hybrid assay. Whereas no effect was seen with the
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alanine-mutated construct AINA (Fig. 1 B, column 10), TINT
mutated to EINE abolished optineurin binding to myosin VI (col-
umn 11) but did not abolish myosin VI binding to Dab2, which
was used as a control. Because the EINE mutation potentially
mimics the phosphorylated form, this data suggests that phos-
phorylation regulates the binding of optineurin to myosin VI.
A GST pull-down assay gave further confirmation that
optineurin binds directly to the tail of myosin VI. In vitro–
translated [
 
35
 
S]methionine labeled optineurin or Dab2 as a pos-
itive control (Fig. 1 C, lanes 2 and 3) were incubated with ei-
ther GST or GST myosin VI tail. The autoradiogram in Fig. 1
C shows that optineurin binds to the myosin VI tail (Fig. 1 C,
lane 5), but not to GST alone (lane 4) or to luciferase as a nega-
tive control protein (lanes 6 and 7). To confirm that myosin VI
binds to optineurin in vivo, we immunoprecipitated endoge-
nous myosin VI and endogenous optineurin from the cytosol of
A431 cells. When myosin VI was immunoprecipitated with
myosin VI tail antibodies optineurin is coimmunoprecipitated
(Fig. 1 D, lane 4), indicating that optineurin and myosin VI ex-
ist in a protein complex in vivo.
 
Mutant myosin VI (
 

 
RRL) does not 
rescue secretion in Snell’s waltzer 
fibroblasts
 
In fibroblastic cell lines derived from Snell’s waltzer mice (sv/
sv) the absence of myosin VI causes a reduction in constitutive
secretion. As shown previously this phenotype can be restored
by overexpression of a fully functional myosin VI (Warner et
al., 2003). To test whether binding of optineurin is essential for
myosin VI function at the Golgi complex in vivo, we per-
formed similar rescue experiments in sv/sv fibroblasts. Immor-
tal fibroblastic sv/sv or wild-type cell lines were stably trans-
 
Figure 1.
 
Optineurin is a myosin VI–binding partner.
 
 (A) A carton show-
ing the major regions in optineurin and myosin VI tail. Optineurin contains
an NH
 
2
 
-terminal Rab8-binding domain (aa 141–209; Hattula and Peranen,
2000) and a COOH-terminal myosin VI–binding domain (aa 412–520).
Myosin VI tail has a proposed helical tail domain (HT) and a globular tail
(GT), which contains the optineurin-binding site RRL in position 1107–
1109. The putative phosphorylation site TINT is at position 1088–1091.
(B) Using the ProQuest yeast two-hybrid screen optineurin was identified
as a myosin interacting protein. The interaction was verified using the
mammalian two-hybrid system. To narrow down the optineurin-binding
site on the myosin VI tail the whole tail (T; column 1), the helical tail
(HT; column 2) or the globular tail (GT) with or without the large insert
(GT
 

 
LI or GT-LI; columns 3 and 4) were fused to the Gal4 DNA-binding
domain and coexpressed with full-length optineurin fused to the VP16 acti-
vating domain in CHO cells. Luciferase activity is shown relative to control
cells containing only the myosin VI construct with the empty prey vector.
Deletion of myosin VI tail at residue 1117 (T
 

 
C; column 5) did not abolish
binding. Mutating three adjacent amino acids each (WKS, KVY, RRL, and
REE to AAA) revealed RRL as the optineurin-binding site (columns 6–9).
Two threonine residues in positions 1088 and 1091 (TINT) were mutated to
either alanine (AINA) or glutamate (EINE; columns 10 and 11). (C) Optineurin
binds to purified myosin VI tail. A pull down was performed using in vitro–
translated optineurin and GST-myosin VI tail. 
 
35
 
S-labeled in vitro–trans-
lated full-length optineurin (lanes 4 and 5), Dab2 as a positive control
(lanes 2 and 3) or luciferase as a negative control (lanes 6 and 7) were
incubated with either 5 
 

 
g GST alone (lanes 2, 4, and 6) or with 5 
 

 
g
GST-myosin VI tail (lanes 3, 5, and 7). Lane 1 shows 50% of the input
used for the pulldown with [
 
35
 
S]optineurin in lane 5. The band below
Dab2 is possibly caused by degradation (lane 3). (D) Co-immunoprecipi-
tation of endogenous myosin VI and optineurin from the cytosol of A431
cells. Immunoprecipitation was performed under native conditions using
no antibody, only protein A beads as a control (lane 2, blank), an anti-
body to full-length optineurin (lane 3, a-Optn) or a pAb to the tail of
myosin VI (lane 4, a-MVI). Lane 1 is equivalent to 5% of the input used for
each immunoprecipitation. Immunoprecipitates were run out on a 10%
PAGE gel, blotted, and analyzed using an antibody to optineurin. (E) Con-
stitutive secretion in Snell’s waltzer fibroblasts cannot be rescued by over-
expression of the mutant myosin VI lacking the optineurin-binding site
(
 

 
RRL). Rescue experiments were performed by generating Snell’s waltzer
cell lines stably expressing only GFP (SV), the mutant myosin VI without the
optineurin-binding site (
 

 
RRL), or wild-type whole myosin VI (MVI). Levels
of secretion were compared with wild-type cells stably expressing only
GFP (WT). To measure constitutive secretion, a construct, which expresses
a SEAP was transfected into the various Snell’s waltzer cell lines and the
wild-type fibroblasts. The amount of alkaline phosphatase secreted into the
media was measured 24, 48, and 72 h after transfection and plotted as a
percentage of total maximal secretion in wild-type cells after 72 h. Trans-
fection efficiency was normalized by cotransfection of a control plasmid
expressing a red fluorescent protein. The data from two separate experi-
ments run in triplicate are shown.
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fected with GFP, GFP-tagged whole wild-type myosin VI
or myosin VI with mutations in the optineurin-binding site
(
 

 
RRL). Constitutive secretion in these stable cell lines was
measured using a soluble secreted form of the alkaline phos-
phatase (SEAP) assay as previously described (Warner et al.,
2003). We observed that only fully functional myosin VI is
able to restore wild-type levels of secretion, whereas cells ex-
pressing myosin VI with the mutant optineurin-binding site are
unable to increase secretion levels back to those of the wild
type (Fig. 1 E).
 
Myosin VI and optineurin colocalize at 
the Golgi complex and in vesicles 
underneath the plasma membrane
 
To test the interaction between myosin VI and optineurin in
vivo, we investigated their intracellular localization in normal
rat kidney (NRK) cells. Previously, both proteins had been lo-
calized independently to the Golgi complex (Buss et al., 1998;
Hattula and Peranen, 2000; Schwamborn et al., 2000; Stroiss-
nigg et al., 2002; Warner et al., 2003). Using an affinity-purified
pAb to optineurin and the TGN marker, TGN38, we confirm
that optineurin is localized at the Golgi complex (Fig. 2, a–c).
Double labeling experiments using optineurin antibodies and an
mAb to myosin VI (Warner et al., 2003) showed considerable
colocalization of both endogenous proteins at the Golgi complex
(Fig. 2, d–f). In addition, both proteins were found in vesicular
structures in the cell periphery close to the plasma membrane
(Fig. 2, g–i and g
 

 
–i
 

 
). We transiently overexpressed optineurin
or fragments of optineurin tagged with either GFP, Flag, or myc
at their COOH or NH
 
2 
 
termini in a number of different cell types
for colocalization studies with the aim of expressing optineurin
mutants that might function as dominant negative. However,
none of the transiently expressed optineurin constructs gave the
same intracellular localization as endogenous optineurin (un-
published data); the overexpressed optineurin was not observed
at the Golgi complex but showed an overall vesicular distribu-
tion and formed aggregates of various sizes in the cytoplasm. It
would appear that the addition of the GFP, Flag, or myc tags to
the NH
 
2
 
 or COOH terminus of optineurin or even to its frag-
ments alters the protein conformation in some way and masks
domains important for intracellular targeting to the Golgi com-
plex. Interestingly, endogenous myosin VI was recruited from
its cytosolic pool into these optineurin aggregates (Fig. 2, j–l),
indicating that the myosin VI–binding site is maintained and ac-
cessible. NH
 
2
 
-terminal optineurin constructs without the myosin
VI–binding domain (aa 412–520) were unable to recruit endog-
enous myosin VI into these aggregates (not depicted). These
results strongly indicate that myosin VI binds to and forms a
protein complex with optineurin in vivo.
 
Depletion of optineurin by siRNA causes 
loss of myosin VI from the Golgi complex
 
Does optineurin play a role in linking myosin VI to the Golgi
complex? To address this question we used siRNA to reduce
cellular expression levels of optineurin (Elbashir et al., 2001).
For the knockdown experiments two siRNA duplexes, specific
for the nucleotide sequence of optineurin, were tested in NRK
and HeLa cells (see Materials and methods) and the best results
were achieved after repeated transfection over a period of 4 d. In
these cells optineurin was depleted to 
 

 
10% of its original level
as shown by Western blotting of equal amounts of mock and
siRNA-treated cells 48 h after the second transfection (Fig. 3 A,
a and B, a). In the same cells expression levels of myosin VI and
actin were unaffected (Fig. 3 A, a and B, a). In the knockdown
cells immunofluorescence microscopy showed that very little
optineurin was present in the Golgi complex (Fig. 3 A, d and B,
d), although in some cells residual cytosolic labeling was appar-
ent (Fig. 3 A, d). To find out what happens to the localization of
myosin VI in optineurin knockdown cells, we double labeled
siRNA and mock-transfected NRK cells with a myosin VI
COOH-terminal globular tail antibody and with antibodies to
GM130 and TGN38. In optineurin-depleted cells there was a
marked reduction in the amount of myosin VI associated with
the Golgi complex (Fig. 4, c and g) as compared with mock-
transfected cells (Fig. 4, a and e) indicating that optineurin plays
a role in anchoring myosin VI to the Golgi complex.
Figure 2. Optineurin and myosin VI colocalize in NRK cells. Endogenous
optineurin localizes to the Golgi complex using a pAb to optineurin (a)
and an mAb to TGN38 (b). Optineurin and myosin VI are localized at the
Golgi complex using a pAb to optineurin (d) and an mAb to myosin VI (e).
Colocalization in vesicular structures close to the plasma membrane was
demonstrated with the pAb to optineurin (g) and by transiently overex-
pressing myosin VI tagged with GFP (h). White boxes indicate areas en-
larged in the pictures below (g, h, and i). Endogenous myosin VI, visual-
ized using the pAb against the whole tail, is recruited into aggregates
containing overexpressed GFP-optineurin (j–k). The merged images are
shown in c, f, i, i, and l. Bars, 10 m.
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Loss of optineurin disrupts the Golgi 
ribbon structure
 
In mammalian cells the Golgi complex is formed by stacks of
flattened membrane cisternae that are interconnected by tubular
membranes into a ribbon like structure (Rambourg and Cler-
mont, 1990). After depolymerization of microtubules using
drugs such as nocodazole, these tubular connections are lost
and the Golgi stacks are disconnected and dispersed throughout
the cells, indicating that the cytoskeleton plays a major role in
maintaining this perinuclear organization of the Golgi complex
(Rogalski and Singer, 1984).
When optineurin was depleted by siRNA transfection in
NRK cells (Fig. 4, d and h) or especially in HeLa cells (Fig. 5,
d–f) there was a dramatic effect on the structure of the Golgi
complex. In the optineurin-depleted HeLa cells the Golgi com-
plex was fragmented into vesicular and sometimes short tubu-
lar structures dispersed throughout the whole cytoplasm. These
Golgi fragments not only contained the Golgi matrix (GM130)
and TGN (TGN46) markers (Fig. 5, d–f) but also markers for
the cis- and medial-Golgi stacks (not depicted). Although the
Golgi matrix and TGN markers were present in a single struc-
ture, they do not completely colocalize, indicating that some
compartmentalization and organization of the Golgi was still
Figure 3. Optineurin is depleted from NRK and HeLa cells using siRNA.
HeLa (A) or NRK (B) cells were either mock transfected with water or trans-
fected twice at 48-h intervals with siRNA specific to optineurin. After 4 d
cells were blotted and probed with antibodies to myosin VI, optineurin, or
actin (A, a and B, a). In a parallel experiment mock-transfected, siRNA-
transfected NRK, or HeLa cells were used for immunofluorescence and
double labeled with antibodies to optineurin (A, b and d; B, b and d)
and GM130 (A, c and e; B, c and e). Bars, 10 m.
Figure 4. Knockdown of optineurin in NRK cells causes loss of myosin VI
from the Golgi complex. Mock-transfected (a, b, e, and f) or siRNA-trans-
fected (c, d, g, and h) NRK cells were used for immunofluorescence and
were double labeled with antibodies to the globular tail of myosin VI (a, c, e,
and g) and antibodies to TGN38 (b and d) or GM130 (f and h). Asterisks
mark the position of the nucleus. Bars, 10 m.
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preserved in these fragments (Fig. 5, d
 

 
–f
 

 
). The Golgi struc-
ture was not disrupted due to a breakdown of the microtubular
network, because this network was still intact in optineurin-
depleted cells (unpublished data).
To characterize the phenotype of optineurin-depleted
cells at the ultrastructural level, electron microscopy was per-
formed on mock and siRNA-treated HeLa cells. In optineurin
knockdown cells mini-stacks of Golgi membranes similar to
those in control cells were still observed (Fig. 5, g and h). This
indicates that although the loss of optineurin caused a break-
down of the Golgi ribbon structure, the overall morphology of
individual Golgi stacks was maintained and no large-scale ve-
siculation was present.
 
Colocalization of myosin VI and Rab8 is 
optineurin dependent
 
Optineurin has been shown to form a link between huntingtin
and Rab8 (Hattula and Peranen, 2000) and optineurin and hun-
tingtin can be colocalized at the Golgi complex (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200501162/
DC1). These proteins are both found at the TGN, in transport
vesicles throughout the cytoplasm and at the plasma membrane
(Huber et al., 1993b; Velier et al., 1998). Optineurin specifi-
cally interacts with wild-type Rab8 and with the constitutively
active GTP-bound mutant Rab8-Q67L, but not with the domi-
nant-negative GDP-bound mutant Rab8-T22N in vitro (Hattula
and Peranen, 2000; Fig. S2 A, available at http://www.jcb.org/
cgi/content/full/jcb.200501162/DC1). By immunofluorescence
optineurin was shown to colocalize with wild-type Rab8 and
the constitutively active Rab8-Q67L at the Golgi complex and
in vesicular and tubular structures in the cytoplasm (Fig. S2 B).
We suggest that optineurin may link myosin VI to Rab8,
as it has been suggested that it links huntingtin to Rab8
(Hattula and Peranen, 2000). To check this idea we deter-
mined the intracellular distribution of myosin VI and Rab8 in
NRK cells. Both proteins showed good colocalization around
the Golgi complex (Fig. 6, a–c), and also in peripheral vesicles
Figure 5. The loss of optineurin results in Golgi fragmentation. Mock (a–c)
or optineurin siRNA-treated HeLa cells (d–f and d–f) were double labeled
in immunofluorescence experiments with TGN46 (b, e, and e) and
GM130 (a, d, and d). White boxes indicate areas enlarged in the
pictures below (d, e, and f). The Golgi fragments contain both marker
proteins as indicated by the yellow color in the merged images (c, f, and f).
The arrows highlight the overlap between the marker proteins in (d–f).
Bars, 10 m. TEM analysis of mock (g) or siRNA-transfected (h) HeLa
cells. Arrows indicate the position of Golgi stacks that can be found in
both mock-transfected and siRNA-transfected cells. Bars, 200 nm.
Figure 6. Myosin VI colocalizes with Rab8 at the Golgi
complex and the plasma membrane. In NRK cells tran-
siently overexpressing Rab8 tagged with GFP (b and e)
myosin VI was detected with an antibody to the globular
tail (a) or to the whole tail (d). Myosin VI and Rab8 are
found in the same labeled structures/vesicles at the Golgi
complex (c) and at the plasma membrane (f). Arrows
indicate vesicles containing both proteins. Bars, 10 m.
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close to the plasma membrane (Fig. 6, d–f). Overexpression of
the constitutively active form of Rab8-Q67L colocalized with
myosin VI at the Golgi complex (Fig. 7, a and b) but also re-
sulted in the formation of long tubular structures emerging
from the Golgi complex (Fig. 7, f and f
 

 
). These long tubular
carriers containing Rab8-Q67L were able to recruit endoge-
nous myosin VI onto their membranes and led to a dramatic re-
distribution of myosin VI (Fig. 7, e and e
 

 
). The recruitment
of myosin VI to these Rab8-positive structures requires op-
tineurin, because in optineurin knockdown cells myosin VI is
no longer present at the fragmenting Golgi complex (Fig. 7, c
and d) or in the tubular structures (Fig. 7, g, h, g
 

 
, and h
 

 
).
 
Transport of VSV-G from the Golgi 
complex to the plasma membrane is 
reduced in optineurin knockdown cells
 
Myosin VI has been shown to be important for constitutive se-
cretion in fibroblasts (Warner et al., 2003). To test whether op-
tineurin as a myosin VI–binding partner present at the Golgi
complex, plays a role in post-Golgi membrane traffic to the cell
surface, we used a thermoreversible folding mutant of the
Figure 7. The recruitment of myosin VI to tubular vesicular structures
formed after overexpression of the constitutively active form of Rab8 is lost
in optineurin-depleted cells. The constitutively active form of Rab8 (GFP-
Rab8-Q67L) overexpressed in NRK cells localizes with myosin VI at the
Golgi complex (a and b) and recruits myosin VI onto tubular and vesicular
structures emerging from the Golgi complex (e and f). In optineurin-depleted
NRK cells, which are overexpressing GFP-Rab8-Q67L myosin VI no longer
colocalizes with Rab8-Q67L at the Golgi complex (c and d) and is not
recruited to tubular and vesicular structures positive for Rab8-Q67L (g and h).
White boxes highlight the areas of the cells enlarged in the pictures below
(e,f, g, and h). Endogenous myosin VI was detected with either a pAb to
the globular tail (a, c, g, and g) or to the whole tail (e and e). Bars, 10 m.
Figure 8. The transport of VSV-G to the cell surface is dramatically reduced
in optineurin-depleted HeLa cells. Mock-treated or siRNA-treated HeLa
cells were transfected with ts045-VSV-G-GFP to measure the rate of exocy-
tosis . VSV-G at the cell surface was detected in indirect immunofluores-
cence using an mAb to the luminal domain of VSV-G and total VSV-G
expressed was detected using a pAb to GFP. (A) Representative cells for
the 40- and 100-min time points are shown to compare the amount of
VSV-G on the cell surface in mock- and optineurin-depleted cells. (B) The
ratio of cell surface over total VSV-G fluorescence was measured as described
in Materials and methods to determine the rate of transport from the Golgi
complex to the cell surface. Error bars: SEM. Bars, 10 m.
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VSV-G fused to GFP at its cytoplasmic tail (ts045 VSV-G-
GFP) as a reporter molecule for membrane transport in the
secretory pathway (Wehland et al., 1982; Kreis and Lodish,
1986; Balch et al., 1994). This membrane protein misfolds and
is retained in the ER at 39.5
 
	
 
C, but upon a temperature shift to
32
 
	
 
C, it can fold and move to the Golgi complex and subse-
quently to the plasma membrane. We measured the amount
of VSV-G at the cell surface relative to the total amount of
VSV-G expressed in the cell using an antibody specific to the
luminal domain of this protein (Pepperkok et al., 1993; See-
mann et al., 2000).
The loss of optineurin has a dramatic effect on transport
of VSV-G from the Golgi complex to the cell surface. After 40
min in mock-transfected cells VSV-G could be detected at the
cell surface (Fig. 8 A, b), whereas in optineurin knockdown
cells it is still found in the fragmented Golgi (Fig. 8 A, c) and
not at the cell surface (Fig. 8 A, d). After 100 min very little
VSV-G still remained in the Golgi complex in the mock-trans-
fected cells and most was on the cell surface (Fig. 8 A, e and f),
however, in the optineurin-depleted cells VSV-G was still re-
tained in the Golgi complex with only a small proportion of it
present on the cell surface (Fig. 8 A, g and h). To quantify these
observations 
 

 
30 cells per time point were measured in two in-
dependent experiments. At every time point less VSV-G was
detected at the plasma membrane of siRNA-treated cells com-
pared with mock-transfected cells (Fig. 8 B). Thus, the trans-
port of VSV-G from the Golgi complex to the cell surface was
dramatically delayed in the optineurin-depleted cells and only
at later time points did it reach 50% of the control levels. These
results clearly indicate that optineurin plays an important role
in post-Golgi membrane trafficking of VSV-G from the Golgi
complex to the cell surface.
 
Discussion
 
We have previously shown that myosin VI is present at the
Golgi complex (Buss et al., 1998) and is involved not only in the
steady-state organization of the Golgi complex but also in post-
Golgi membrane traffic (Warner et al., 2003). To investigate the
precise roles that myosin VI plays in these processes we identi-
fied optineurin, a peripheral Golgi protein as a binding partner
for myosin VI. This interaction found in a yeast two-hybrid
screen was confirmed using a range of different protein–protein
interaction studies. Myosin VI and optineurin colocalize at the
Golgi complex and in vesicular structures close to the plasma
membrane. The loss of optineurin not only leads to Golgi frag-
mentation and a reduction in exocytosis, but we also show that
optineurin is essential for targeting myosin VI to the Golgi com-
plex. Most interestingly optineurin plays a role in colocalizing
myosin VI and Rab8, a member of the Rab family of G-proteins,
which are important regulators of membrane traffic events.
Optineurin binds directly to the sequence RRL (residues
1107–1109) in the globular tail of myosin VI. This binding site
is distinct from the Dab2-binding site and is independent of the
large insert. The binding of optineurin to myosin VI is regulated
by phosphorylation at the TINT (1088–1091) site in the globu-
lar tail region. Our results suggest that a PAK phosphorylates
myosin VI not only in the motor domain (Buss et al., 1998) but
also in the globular tail domain at threonine 1088 and 1091,
thus coordinating the regulation of motor function with cargo
binding in the tail domain.
In the absence of optineurin the Golgi complex is frag-
mented. The ribbon structure of interconnected stacks of mem-
brane cisternae is broken up and the disconnected Golgi stacks
are dispersed throughout the cytoplasm. The overall appearance
of the fragmented Golgi stacks, however, is similar to the ap-
pearance of the Golgi in control cells and no gross vesiculation
was observed at the EM level. Golgi resident proteins such as
TGN46 and GM130 were still present in the Golgi fragments.
These morphological changes are very similar to those ob-
served when microtubules are disrupted by drugs such as no-
codazole (Rogalski and Singer, 1984), suggesting that op-
tineurin might be involved in linking Golgi membranes directly
or indirectly to microtubules around the microtubule organizing
center (MTOC). One of the optineurin-binding partners is hun-
tingtin, known to interact with HAP1 (Huntingtin-associated
protein; Li et al., 1995), which binds directly to the dynactin
subunit p150
 
glued
 
 (Engelender et al., 1997; Li et al., 1998a). The
dynactin complex is involved in linking the minus end directed
microtubule motor protein dynein to membrane vesicles (Gill et
al., 1991). It has been proposed that huntingtin and HAP1 act as
scaffolding proteins regulating the interaction between the dy-
nein–dynactin complex and cargo such as Golgi membranes
(Harjes and Wanker, 2003). The absence or inactivation of cy-
toplasmic dynein leads to fragmentation and spreading of the
Golgi complex into the cytoplasm (a phenotype similar to that
observed after the loss of optineurin; Harada et al., 1998); thus
it is possible that optineurin via the huntingtin–HAP1 complex
may be involved in targeting dynein to Golgi membranes (Fig.
9). Recent results (Gauthier et al., 2004) indicate a further role
for the huntingtin–HAP1 complex in the axonal transport of
vesicles containing brain-derived neurotrophic factor along mi-
crotubules and highlight the importance of huntingtin-binding
partners in the progression of the disease.
The loss of optineurin not only disrupts the structure of
the Golgi complex, but also dramatically reduces secretion of
VSV-G to the plasma membrane. Reduced transport is not due
to Golgi fragmentation because Golgi stacks dispersed by de-
polymerization of microtubules remain fully functional with
only a slight reduction in protein secretion (Van De Moortele et
al., 1993). Reduced exocytosis of VSV-G in the optineurin
knockdown cells is a very similar phenotype to that observed in
the myosin VI knockout mouse, where secretion of alkaline
phosphatase is also significantly reduced (Warner et al., 2003).
Secretion in these cells lacking myosin VI is not restored by
mutant myosin VI, which is unable to bind to optineurin, indi-
cating that a functional complex between myosin VI and op-
tineurin is required for constitutive exocytosis.
Rab8 binds to optineurin and plays an important role in
polarized membrane transport both from the Golgi complex to
the basolateral membrane in polarized epithelial cells and to
dendrites in neurons (Huber et al., 1993a,b). Rab8 is present in
the same intracellular compartments as myosin VI and in this
paper we show that myosin VI and Rab8 colocalize in the peri-
 OPTINEURIN LINKS MYOSIN VI TO THE GOLGI COMPLEX • SAHLENDER ET AL.
 
293
 
nuclear region around the Golgi complex and both are present
on the same vesicles underneath the plasma membrane. In ad-
dition Rab8 has been localized to the recycling endosome, a
compartment shown to be involved in post-Golgi membrane
trafficking to the plasma membrane (Ang et al., 2003, 2004).
However, at present we don’t know whether some myosin VI is
also associated with the fraction of Rab8 present in the recy-
cling endosome. On the other hand because Rab8 may interact
via optineurin with myosin VI it suggests a possible pathway
whereby TGN-derived vesicles are transported short distances
along actin filaments by myosin VI, before a kinesin motor
picks up the cargo for long distance transport along microtu-
bules. Similarly, close to the plasma membrane the Rab8–
optineurin–myosin VI complex might be involved in presenting
the secretory vesicle to the docking site, thus tethering the vesi-
cle close to the plasma membrane before fusion. Overexpres-
sion of Rab8-Q67L leads to the formation of long tubular ex-
tensions from the Golgi complex and it recruits endogenous
myosin VI onto these tubular structures. These results indicate
that Rab8 serves as a membrane receptor for myosin VI, re-
cruiting this myosin motor onto a specific intracellular mem-
brane compartment via optineurin. Similarly, it was shown re-
cently that Rab27a recruits myosin Va onto melanosomes via
the linker molecule melanophillin (Seabra and Coudrier, 2004).
Optineurin is the first myosin VI–binding partner identi-
fied at the Golgi complex and may play an adaptor or linker
role. The recent demonstration that myosin VI can exist as a
nonprocessive monomer (Lister et al., 2004) and also possibly
as a processive dimer (Rock et al., 2001; Nishikawa et al.,
2002) may provide a mechanism for the distinct dual roles for
myosin VI in structural maintenance and vesicle transport ac-
tion away from the Golgi complex. We therefore suggest that
optineurin may serve two major “linker” functions for myosin
VI in the Golgi complex (Fig. 9): First, optineurin together
with huntingtin links via the minus end directed motor dynein
to the microtubule network and also by directly interacting
with myosin VI, is linked to the actin cytoskeleton, thus it may
play a role in coordinating microtubule-based and actin-based
motor activity around the Golgi complex. Support for such a
role is provided by our previous observation that in Snell’s
waltzer mice the absence of myosin VI causes a reduction in
the size of the Golgi complex (Warner et al., 2003), which
would be due to the dynein motor complex pulling the Golgi
membranes in toward the MTOC resulting in a smaller more
compact Golgi complex. Therefore, in the absence of myosin
VI the balance of motor proteins is disturbed and dynein wins
the “tug of war”. Second, optineurin might link myosin VI to
Rab8, a regulatory protein known to be involved in sorting
molecules in the exocytic pathway at the TGN and in mem-
brane fusion at the plasma membrane. The linker function of
optineurin may be temporally regulated, for example by phos-
phorylation of individual proteins, including myosin VI and
optineurin (Schwamborn et al., 2000).
In addition, because optineurin is obviously a dimer with
multiple leucine zippers it may induce monomeric myosin VI
to dimerize for processive movement of vesicles from the TGN
to the plasma membrane.
Our work provides new information on the intracellular
functions of optineurin, which will help elucidate how muta-
tions in the optineurin gene lead to primary open angle glau-
coma (Rezaie et al., 2002). Previous reports, that reduced secre-
tion of the glycoprotein myocilin leads to primary open angle
glaucoma (Joe et al., 2003), support our results that optineurin
plays a major role in Golgi morphology and exocytosis.
 
Materials and methods
 
Antibodies
 
The following antibodies were used: affinity-purified rabbit pAb to hu-
man full-length optineurin (
 

 
-Optn; GenBank/EMBLDDBJ accession no.
AF061034); monoclonal 
 

 
-VSV-G to the luminal domain (a gift from R.
Pepperkok and J. Simpson, EMBL, Heidelberg, Germany); polyclonal 
 

 
-opti-
neurin (Cayman); monoclonal 
 

 
-GM130 (BD Transduction Laboratories);
monoclonal 
 

 
-TGN38 (Luzio et al., 1990); monoclonal 
 

 
-GFP (Qbiogene);
polyclonal 
 

 
-GFP (Molecular Probes); monoclonal, polyclonal 
 

 
-TGN46
(Serotec); and monoclonal and pAbs to the whole tail (
 

 
-MVI) and globu-
lar tail of myosin VI (
 

 
-MVI-GT; Buss et al., 1998; Warner et al., 2003).
 
Yeast two-hybrid screen
 
Myosin VI interacting proteins were identified in a ProQuest Two-Hybrid
System (Invitrogen) using the tail domain of chicken intestinal brush border
myosin VI (amino acids 846–1277) containing the large insert to screen a
human umbilical vein epithelial cell cDNA library (provided by M. McCor-
mack and T. Rabbits, MRC-LMB, Cambridge, UK) as described previously
(Morris et al., 2002). 100 mM 3-amino-1,2,4-TRIzol was used to overcome
the observed self-activation by the myosin VI tail domain. The potential myo-
sin VI tail domain interacting proteins were identified in the yeast two-
hybrid screen by selecting transformants that were able to grow on plates
lacking leucine, tryptophan, and histidine in the presence of 100 mM
3-amino-1,2,4-TRIzol. Colonies containing candidate cDNAs for interacting
proteins were isolated and replated on selection agar to test for activation
of the three reporter genes 
 
HIS3
 
, 
 
URA3
 
, and 
 
lacZ. Colonies positive for all
three reporter genes were confirmed in the mammalian two-hybrid assay.
Cloning of optineurin and construction of pEGFP-Rab8-Q67L
The full-length version of human optineurin cDNA was generated by PCR
from Caco-2 cDNA and subcloned into pEGFP (Clontech) or pRSET (Invitro-
gen) for pAb production. pEGFP-Rab8 WT, containing the human wild-type
Figure 9. A cartoon illustrating the possible interaction of optineurin with
motor protein complexes at the Golgi complex. Optineurin may play a
central role in coordinating actin-based and microtubule-based motor func-
tion for maintaining Golgi morphology. The optineurin-binding partner
huntingtin has been shown to interact with HAP1, which in turn was reported
to form a complex with the dynactin subunit p150glued and modulate/
regulate the dynein–dynactin complex. Loss of minus end–directed dynein
motor activity causes in fragmentation of the Golgi ribbon structure. On
the other hand loss of myosin VI results in a reduction in the size of the
Golgi complex, because now the dynein complex is still active and able to
retract the Golgi complex toward the MTOC. However, if optineurin is
depleted, both motor complexes are nonfunctional and the Golgi complex
is fragmented.
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Rab8 cDNA sequence (GenBank/EMBL/DDBJ accession no. 498943)
was a gift from P. Row (University of Liverpool, Liverpool, UK) and H.
Davidson (University of Colorado, Denver, CO). The constitutively active
form of Rab8, Rab8-Q67L, was generated by QuikChange Site-Directed
Mutagenesis (Stratagene) according to the manufacturer’s instructions.
Mammalian two-hybrid assay
Chicken myosin VI tail fragments HT (aa 845–1033) and TC (aa 845–
1117) were generated by PCR and inserted into the pM “bait” vector
(CLONTECH Laboratories, Inc.). The following alanine mutations were
generated using QuikChange Site-Directed Mutagenesis (Stratagene):
WKS, KVY, RRL, and REE to AAA at aa positions 1115–1117, 1110–
1112, 1107–1109, and 1102–1104, respectively, (named TWKS, etc.)
along with T1088A/T1091A and T1088E/T1091E double mutants. T
(chicken Myosin VI whole tail with the large insert (LI)), CC (aa 846–
1034), GTLI (aa 1035–1277), and GT-LI (aa 1061–1277) were con-
structed previously (Morris et al., 2002). The mammalian two-hybrid as-
say was performed as previously described (Morris et al., 2002).
Cell culture and transfection
NRK cells, CHO cells, and HeLa cells were cultured as described before
(Buss et al., 1998). For transient transfection experiments cells were trans-
fected either with 2 g of pEGFP-optineurin, pEGFP-MyosinVI, pEGFP-
Rab8-WT, or pEGFP-Rab8-Q67L for 16–18 h using FuGENE (Roche Diag-
nostics) according to the manufacturer’s instructions. Snell’s waltzer mouse
immortal cell lines (Warner et al., 2003) were transfected using the MEF-1
Nucleofector kit (Amaxa Biosystems) according to the manufacturer’s in-
structions with chicken full-length myosin VI, the mutant myosin VI (RRL), or
only GFP cloned into pMEP (Buss et al., 2001a). The cells were grown
and selection performed as previously described (Warner et al., 2003).
SEAP expression and assay
Snell’s waltzer fibroblasts (SV), wild-type fibroblasts (WT; Warner et al.,
2003) and Snell’s waltzer expressing either full-length wild-type myosin VI-
GFP (MVI) or the mutant myosin VI (RRL) were transiently transfected with
the pSEAP2-control mammalian expression plasmid (CLONTECH Laborato-
ries, Inc.) containing SEAP cDNA using the MEF-1 Nucleofector kit (Amaxa
Biosystems) according to the manufacturer’s instructions. The SEAP assay
was performed as previously described (Warner et al., 2003).
Knockdown of optineurin by siRNA
HeLa and NRK cells were transfected with siRNA duplex (20 M; Dhar-
macon Research) using OligofectAMINE (Invitrogen) according to the
manufacturer’s manual. For efficient knockdown of optineurin cells were
transfected twice with siRNA duplex on day 1 and day 3. On day 5 cells
were processed for indirect immunofluoresence and the efficiency of
knockdown was assayed by Western blotting. In the mock experiment
the siRNA duplex was substituted with H2O. Human and rat optineurin
were targeted with two independent siRNAs: 5-CCACCAGCTGAAA-
GAAGCC-3 and 5-CTGCAGCTCAAGCTGAACT-3. Both siRNAs gave
the same level of knockdown and phenotypes in optineurin-depleted cells.
Indirect immunofluorescence microscopy
Indirect immunofluorescence staining was performed as described in Buss et
al. (1998). To visualize optineurin at the Golgi complex, cells were pre-per-
meabilized with 0.05% saponin in cytosol buffer (Morris and Cooper, 2001)
for 30 s. Cells were analyzed and photographed using 63
 or 100
 objec-
tives of an Axiophot microscope (Carl Zeiss MicroImaging, Inc.) equipped
with a CCD camera. Images were further processed in Adobe Photoshop.
VSV-G-GFP transport assay
4-d mock- or siRNA-treated HeLa cells were transfected with ts045G VSV-
G-GFP (a gift from R. Duden, University of London, London, UK) using Fu-
GENE as described above. Cells were first incubated for 2 h at 37	C and
then for 15 h at 39.5	C. Before a temperature shift from 39.5	C to 32	C,
100 g/ml cycloheximide (Sigma-Aldrich) was added to each dish and
cells were incubated at 4	C for 30 min. After 20, 40, 60, and 100 min at
32	C cells were fixed with 4% PFA and VSV-G present on the cell surface
detected with an mAb to the luminal domain of VSV-G. GFP fluorescence
gave the total amount of VSV-G expressed in the cell. The ratio of cell sur-
face over total fluorescence was calculated as described previously (Pep-
perkok et al., 1993; Seemann et al., 2000) using IP lab software.
Immunoprecipitation and immunoblotting
For immunoprecipitation A431 cells were lysed and sonicated in extrac-
tion buffer containing PBS, 1 mM EDTA, 5 mM ATP, 5 mM MgCl2, 0.5%
IGEPAL CA-630 (Sigma-Aldrich) and protease inhibitor cocktail (Com-
plete; Roche) and processed for immunoprecipitation followed by SDS
PAGE and immunoblotting as described previously (Buss et al., 1998).
GST pull-down assay
The chicken brush border myosin VI tail residues 840–1277 tagged with
GST was expressed in E. coli BL21 (DE3) cells and purified as described
previously (Buss et al., 1998). Full-length optineurin and Dab2 were
cloned into pcDNA3 (Invitrogen) and in vitro translated using the TNT-cou-
pled Reticulocyte Lysate System (Promega). The [35S]methionine in vitro–
translated protein was incubated for 2 h at 4	C with 5 g of GST or GST
myosin VI tail coupled to glutathione beads in 10 mM Hepes, pH 7.4,
150 mM NaCl, 1% Triton X-100. After extensive washing the protein com-
plexes bound to glutathione beads were separated by SDS PAGE and an-
alyzed by autoradiography.
Transmission electron microscopy
Cells were grown in 6-cm tissue cultures dishes and fixed with 2.5% glu-
taraldehyde/2% PFA in 0.1 M Na cacodylate buffer, pH 7.2, at 37	C.
After washing with 0.1 M Na cacodylate buffer, pH 7.2, cells were fixed
after in 1% osmium tetroxide in 0.1 M Na cacodylate buffer, pH 7.2, for
1 h and washed with 0.05 M Na maleate buffer, pH 5.2. The cells were
then en bloc stained with 0.5% uranyl acetate in 0.05 M Na maleate
buffer, pH 5.2, dehydrated in ethanol, exchanged into 1,2-epoxy pro-
pane, and embedded in Araldite CY212 epoxy resin (Agar Scientific).
Ultrathin sections were collected on EM grids and stained with uranyl ac-
etate and Reynolds lead citrate. The sections were observed in a transmis-
sion electron microscope (model CM100; Philips Electron Optics) at an
operating voltage of 80 kV.
Online supplemental material
Fig. S1 shows colocalization of optineurin with wild-type huntingtin at the
Golgi complex in HeLa cells. Fig. S2 A demonstrates that optineurin binds
to wild-type Rab8 and the Rab8 Q67L mutant but not the Rab8 T22N mu-
tant in vitro. Fig. S2 B shows colocalization of endogenous optineuin with
wild-type GFP-Rab8 and the GFP-Rab8 Q67L mutant at the Golgi com-
plex and in vesicular structures throughout the cytosol. Online supplemen-
tal material is available at http://www.jcb.org/cgi/content/full/jcb.
200501162/DC1.
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